Nord/LB set a €60.00 ($74.07) target price on Carl Zeiss Meditec (ETR:AFX) in a research note published on Monday morning. The firm currently has a buy rating on the stock.

Other equities analysts have also recently issued research reports about the stock. set a €52.00 ($64.20) price objective on shares of Carl Zeiss Meditec and gave the company a buy rating in a research report on Friday, November 10th. Berenberg Bank set a €48.00 ($59.26) target price on shares of Carl Zeiss Meditec and gave the company a buy rating in a research note on Friday, December 8th. Hauck & Aufhaeuser set a €62.50 ($77.16) target price on shares of Carl Zeiss Meditec and gave the company a buy rating in a research note on Thursday, February 8th. Kepler Capital Markets set a €48.50 ($59.88) target price on shares of Carl Zeiss Meditec and gave the company a neutral rating in a research note on Monday. Finally, Deutsche Bank set a €48.00 ($59.26) target price on shares of Carl Zeiss Meditec and gave the company a neutral rating in a research note on Monday, January 22nd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company. The stock has a consensus rating of Hold and an average target price of €52.88 ($65.28).

Carl Zeiss Meditec (ETR AFX) opened at €49.48 ($61.09) on Monday. Carl Zeiss Meditec has a 52-week low of €37.35 ($46.11) and a 52-week high of €55.25 ($68.21). The stock has a market cap of $4,430.00 and a PE ratio of 32.77.

TRADEMARK VIOLATION WARNING: “Carl Zeiss Meditec (AFX) Given a €60.00 Price Target at Nord/LB” was originally published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this news story on another site, it was stolen and republished in violation of US and international copyright & trademark laws. The correct version of this news story can be viewed at https://theolympiareport.com/2018/02/15/carl-zeiss-meditec-afx-given-a-60-00-price-target-at-nord-lb.html.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.